Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Urges Biden Administration to Work Alongside…
The Biotechnology Innovation Organization (BIO) released the following statement in response to a bipartisan letter signed by 21 members of the U.S. House of Representatives. Led by Reps. Randy Feenstra (R-IA) and Dan Kildee (D-MI), the letter urged…
Learn more
Virginia Governor Glenn Youngkin named BIO’s…
WASHINGTON, DC (September 17, 2024) – Today, the Biotechnology Innovation Organization (BIO) awarded Virginia Governor Glenn Youngkin with its 2024 Governor of the Year Award. BIO’s annual award honors governors for their leadership and…
Learn more
New Season of “I am BIO” Podcast Explores Patient…
WASHINGTON - (September 5, 2024) –The Biotechnology Innovation Organization (BIO) will launch the fall season of the award-winning “I am BIO” podcast on September 10. Now entering its fifth year, the podcast explores the intersection of…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
The Creating Hope Reauthorization Act of 2024 Offers Hope to Kids Suffering From Rare Diseases
February 15, 2024
The Creating Hope Reauthorization Act of 2024 was introduced in the House of Representatives this week. BIO CEO and President, Rachel King, made the following statement following the bill's introduction: "BIO strongly supports the House…
House passage of bill to restore full R&D expensing a "big step forward" for biomedical innovation
February 1, 2024
Legislation to restore immediate R&D expensing passed the House by 357-70 yesterday. Following the vote, BIO's Chief Advocacy Officer, Nick Shipley, made the following statement:  "The bipartisan legislation passed by the U.S. House…
Bipartisan EPIC Act a "critical step forward" to incentivize small molecule drug innovation
January 31, 2024
Yesterday, Reps. Greg Murphy, M.D. (R-NC), Don Davis (D-NC) and Brett Guthrie introduced the Ensuring Pathways to Innovative Cures (EPIC Act), legislation to fix the “pill penalty.” BIO President and CEO, Rachel King, made the following statement: …
New BIO Report Finds More Innovation & Investment Needed in Vaccine Development
January 25, 2024
Today, the Biotechnology Innovation Organization (BIO) released a new report, "The State of Innovation in Vaccines and Prophylactic Antibodies for Infectious Diseases," examining the latest scientific and investment trends in vaccine development…
BIO and ICBA Release Updated Report on Biotechnology’s Role in Meeting UN Sustainable Development Goals
December 21, 2023
The Biotechnology Innovation Organization (BIO) released an updated report produced in partnership with the International Council of Biotechnology Associations (ICBA) that highlights biotechnology’s role in meeting the United Nations’ 17 Sustainable…
BIO Applauds U.N. FAO on Food and Climate Roadmap
December 14, 2023
The Biotechnology Innovation Organization (BIO) today welcomed the United Nations (U.N.) Food and Agriculture Organization’s announcement of a new roadmap outlining how the world can attain global food security by 2050 without breaching the global…
SCOTUS should preserve FDA's "mandated authority" and "scientific and medical expertise" in new case
December 13, 2023
Today, the Supreme Court announced it will soon weigh in on a case that challenges how the Food and Drug Administration (FDA) regulates mifepristone, a drug it approved almost 25 years ago. BIO interim president and CEO, Rachel King, made the…
New Survey Finds Majority of Americans Support Incentivizing Biotech to Address Climate Change
December 8, 2023
Most Americans Recognize that Biotech Is ‘Climate Tech’ A new poll from the Biotechnology Innovation Organization (BIO) shows that majorities of Americans agree that biotech plays an important role in addressing climate change and federal…
New BIO Poll Reveals Americans Strongly Support the Orphan Cures Act
December 7, 2023
Today, the Biotechnology Innovation Organization released a poll that shows voters overwhelmingly support the ORPHAN Cures Act, a recently introduced bill that would incentivize rare disease drug development.   The…
Using March-In as a Price Control Mechanism Is a “Dangerous Precedent To Set”
December 7, 2023
The White House just announced plans to use Bayh-Dole “march-in rights” to step in and license patent rights of drugs “developed with federal funding” to other manufacturers when the price of the drug is deemed too high. BIO's Chief Advocacy Officer…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today